Atlanta, Georgia 30322


Purpose:

The study is a randomized controlled trial to evaluate the social capital intervention versus a general health promotion intervention (Health for Life; H4L) among groups of Young black men who have sex with men (YBMSM) and to measure the social capital and engagement in care with the HIV-positive YBMSM at 3 and 9 months.


Study summary:

Young black men who have sex with men (YBMSM) have high rates of HIV infection, and are also at risk for falling out of clinical care. Social capital, which refers to the resources in a person's social network, has been shown to be beneficial for people living with HIV in other places. The study wants to understand and build upon social capital in the YBMSM population in Atlanta, with the goal of ultimately improving HIV-related outcomes for these youth. To achieve this study is conducted in 3 phases. In Phase I, study will conduct interviews with YBMSM and community leaders to get advice about developing a social capital intervention that will improve social capital. Phase II is a randomized controlled trial of groups of YBMSM implementing the social capital intervention versus groups of YBMSM receiving a general health promotion intervention (Health for Life; H4L). This is followed by Phase III which is mainly to measure the social capital and engagement in care with the HIV-positive YBMSM at 3 and 9 month timepoints. The study plan to enroll 180 total participants (120 in the randomized controlled trial and 60 in preliminary interviews) over the four year study period.


Criteria:

Inclusion Criteria: - Age <= 29 years and >= 18 years - Self-identify as Black/African-American (inclusive of multiracial identities) - Male sex at birth - Endorse history of sex with men ever (inclusive of gay and bisexual men) - HIV-positive (self-reported by participant and confirmed by medical record) - Able and willing to provide written consent and participate in surveys, interviews, and/or group intervention Exclusion Criteria: - Age < 18 years or >= 30 years - Unwilling or unable to provide written informed consent - Enrollment in one phase of the study is an exclusion criteria for enrollment in other phases


NCT ID:

NCT03664817


Primary Contact:

Principal Investigator
Sophia Hussen, M.D., M.P.H.
Emory University

Sophia Hussen, M.D., M.P.H.
Phone: 404-727-2446
Email: sophia.ahmed.hussen@emory.edu


Backup Contact:

N/A


Location Contact:

Atlanta, Georgia 30322
United States

Sophia Hussen, M.D., M.P.H.
Phone: 404-727-2446
Email: sophia.ahmed.hussen@emory.edu

Site Status: Recruiting


Data Source: ClinicalTrials.gov

Date Processed: February 04, 2019

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

If you would like to be contacted by the clinical trial representative please fill out the form below.